These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9258245)
1. Altered thymic endocrine activity along with impairments of peripheral zinc metabolism and T-lymphocyte populations are associated with myasthenia gravis: a follow-up study. Licastro F; Mocchegiani E; Fabris N; Rinaldi R; Bontempo G; Tonon C; Schiavina M; Costa AN; D'Alessandro R J Neuroimmunol; 1997 Aug; 77(2):153-60. PubMed ID: 9258245 [TBL] [Abstract][Full Text] [Related]
2. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. Sempowski G; Thomasch J; Gooding M; Hale L; Edwards L; Ciafaloni E; Sanders D; Massey J; Douek D; Koup R; Haynes B J Immunol; 2001 Feb; 166(4):2808-17. PubMed ID: 11160348 [TBL] [Abstract][Full Text] [Related]
3. Different age-related effects of thymectomy in myasthenia gravis: role of thymoma, zinc, thymulin, IL-2 and IL-6. Mocchegiani E; Giacconi R; Muzzioli M; Gasparini N; Provinciali L; Spazzafumo L; Licastro F Mech Ageing Dev; 2000 Aug; 117(1-3):79-91. PubMed ID: 10958925 [TBL] [Abstract][Full Text] [Related]
4. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825 [TBL] [Abstract][Full Text] [Related]
5. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy. Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188 [TBL] [Abstract][Full Text] [Related]
6. Analysis of prognostic factors in thymectomized patients with myasthenia gravis: correlation between thymic lymphoid cell subsets and postoperative clinical course. Fujii N; Itoyama Y; Machi M; Goto I J Neurol Sci; 1991 Oct; 105(2):143-9. PubMed ID: 1721934 [TBL] [Abstract][Full Text] [Related]
7. CD4 Kohler S; Keil TOP; Hoffmann S; Swierzy M; Ismail M; Rückert JC; Alexander T; Meisel A Clin Immunol; 2017 Jun; 179():40-46. PubMed ID: 28286113 [TBL] [Abstract][Full Text] [Related]
8. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy. Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565 [TBL] [Abstract][Full Text] [Related]
9. A decrease in the percentage of CD3+ cells is correlated with clinical improvement during plasmapheresis in patients with myasthenia gravis. Chien PJ; Yeh JH; Shih CM; Hsueh YM; Chen MC; Chiu HC Artif Organs; 2013 Feb; 37(2):211-6. PubMed ID: 23020831 [TBL] [Abstract][Full Text] [Related]
10. Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis. Melms A; Malcherek G; Gern U; Sommer N; Weissert R; Wiethölter H; Bühring HJ J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):46-51. PubMed ID: 8094093 [TBL] [Abstract][Full Text] [Related]
11. Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells. Jakubíková M; Piťha J; Marečková H; Týblová M; Nováková I; Schutzner J J Neurol Sci; 2015 Nov; 358(1-2):101-6. PubMed ID: 26320610 [TBL] [Abstract][Full Text] [Related]
12. [Effects of thymectomy and glucocorticoid therapy on peripheral lymphocytes in myasthenia gravis]. Huang Y; Xu X; Lin J Zhonghua Nei Ke Za Zhi; 1995 Aug; 34(8):514-7. PubMed ID: 8697907 [TBL] [Abstract][Full Text] [Related]
13. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients. Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705 [TBL] [Abstract][Full Text] [Related]
14. Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression. Crosti F; Armanini M; Confalonieri P; Antozzi C; Mantegazza R J Neurol; 1994 Feb; 241(4):218-22. PubMed ID: 8195820 [TBL] [Abstract][Full Text] [Related]
15. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis. Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934 [TBL] [Abstract][Full Text] [Related]
16. Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis. Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Itoyama Y J Neuroimmunol; 2005 Oct; 167(1-2):186-9. PubMed ID: 16040133 [TBL] [Abstract][Full Text] [Related]
17. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity. Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579 [TBL] [Abstract][Full Text] [Related]
18. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Mocchegiani E; Santarelli L; Muzzioli M; Fabris N Int J Immunopharmacol; 1995 Sep; 17(9):703-18. PubMed ID: 8582782 [TBL] [Abstract][Full Text] [Related]
19. Zinc and metallothioneins on cellular immune effectiveness during liver regeneration in young and old mice. Mocchegiani E; Verbanac D; Santarelli L; Tibaldi A; Muzzioli M; Radosevic-Stasic B; Milin C Life Sci; 1997; 61(12):1125-45. PubMed ID: 9315504 [TBL] [Abstract][Full Text] [Related]
20. Changes in human T lymphocytes after thymectomy and during senescence. Van de Griend RJ; Carreno M; Van Doorn R; Leupers CJ; Van den Ende A; Wijermans P; Oosterhuis HJ; Astaldi A J Clin Immunol; 1982 Oct; 2(4):289-95. PubMed ID: 6216263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]